SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001013594-23-000205
Filing Date
2023-02-14
Accepted
2023-02-14 09:58:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 theravance13ga2-021422.htm SC 13G/A 115396
  Complete submission text file 0001013594-23-000205.txt   116947
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Subject) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88552 | Film No.: 23623748
SIC: 2834 Pharmaceutical Preparations

Mailing Address 150 EAST 58TH STREET 14TH FLOOR NEW YORK NY 10155
Business Address 150 EAST 58TH STREET 14TH FLOOR NEW YORK NY 10155 212-702-8644
Madison Avenue Partners, LP (Filed by) CIK: 0001801265 (see all company filings)

IRS No.: 320567414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A